SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs1541331 | chr9:133050630 (GRCh38.p7) | A>G | alcohol dependence | SNV(Single Nucleotide Variation) |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
LZTS2 | 0.918 |
GGA1 | 0.917 |
WDR59 | 0.915 |
CYTH1 | 0.912 |
PRKCSH | 0.906 |
FAM50A | 0.903 |
ARHGAP1 | 0.902 |
XAB2 | 0.902 |
ZBTB17 | 0.899 |
KIAA2013 | 0.898 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.708 |
OR4F29 | -0.684 |
MTRNR2L9 | -0.284 |
MTRNR2L6 | -0.281 |
MTRNR2L10 | -0.253 |
TTLL10-AS1 | -0.242 |
UNC45B | -0.241 |
C10orf71 | -0.239 |
OR4F16 | -0.238 |
KRT73 | -0.236 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of GTF3C5 mRNA" | 21346803 |
C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of GTF3C5 mRNA" | 18648102 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of GTF3C5 mRNA | 22230336 |
D000082 | Acetaminophen | Acetaminophen affects the expression of GTF3C5 mRNA | 17562736 |
C103505 | AM 251 | AM 251 results in decreased expression of GTF3C5 mRNA | 16500647 |
C006780 | bisphenol A | bisphenol A affects the expression of GTF3C5 mRNA | 21786754 |
C006780 | bisphenol A | bisphenol A affects the expression of GTF3C5 mRNA | 25181051 |
D000068579 | Celecoxib | Celecoxib results in increased expression of GTF3C5 mRNA | 28201806 |
C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in decreased expression of GTF3C5 mRNA | 23640034 |
D002945 | Cisplatin | Cisplatin results in increased expression of GTF3C5 mRNA | 27594783 |
D007213 | Indomethacin | Indomethacin results in increased expression of GTF3C5 mRNA | 28201806 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of GTF3C5 mRNA | 26011545 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of GTF3C5 mRNA | 23649840 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of GTF3C5 protein | 21925251 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of GTF3C5 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of GTF3C5 mRNA | 21215274 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of GTF3C5 gene | 29154799 |
D014635 | Valproic Acid | Valproic Acid affects the expression of GTF3C5 mRNA | 17292431|1796380 |
D014638 | Vanadates | Vanadates results in decreased expression of GTF3C5 mRNA | 22714537 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of GTF3C5 gene | 25560391 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000995 | RNA polymerase III general transcription initiation factor activity | CONTRIBUTES_TO | IBA | 21873635 |
GO:0001002 | RNA polymerase III type 1 promoter sequence-specific DNA binding | CONTRIBUTES_TO | IBA | 21873635 |
GO:0001003 | RNA polymerase III type 2 promoter sequence-specific DNA binding | CONTRIBUTES_TO | IBA | 21873635 |
GO:0003677 | DNA binding | contributes_to | IC | 17409385 |
GO:0005515 | protein binding | - | IPI | 17409385 25416956 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0006351 | transcription, DNA-templated | - | IC | 17409385 |
GO:0006383 | transcription by RNA polymerase III | - | IC | 17409385 |
GO:0035914 | skeletal muscle cell differentiation | - | IEA | - |
GO:0042791 | 5S class rRNA transcription by RNA polymerase III | - | IC | 17409385 |
GO:0042797 | tRNA transcription by RNA polymerase III | - | IC | 17409385 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000127 | transcription factor TFIIIC complex | - | IBA | 21873635 |
GO:0000127 | transcription factor TFIIIC complex | - | IDA | 17409385 |
GO:0005654 | nucleoplasm | - | IDA | - |
GO:0005654 | nucleoplasm | - | TAS | - |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-74158 | RNA Polymerase III Transcription | IEA |
R-HSA-74158 | RNA Polymerase III Transcription | TAS |
R-HSA-74160 | Gene expression (Transcription) | IEA |
R-HSA-74160 | Gene expression (Transcription) | TAS |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | IEA |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | IEA |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | TAS |
R-HSA-76061 | RNA Polymerase III Transcription Initiation From Type 1 Promoter | IEA |
R-HSA-76061 | RNA Polymerase III Transcription Initiation From Type 1 Promoter | TAS |
R-HSA-76066 | RNA Polymerase III Transcription Initiation From Type 2 Promoter | IEA |
R-HSA-76066 | RNA Polymerase III Transcription Initiation From Type 2 Promoter | TAS |
PMID | Title (Year) | Author | Journal |
---|